Cancer du poumon à l’ère du COVID-19

Chouaïd, C.

doi:10.1016/s1877-1203(20)30155-5

Cited by 2 publications

(2 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Many medical centers aim to control its spread by implementing isolation protocols (1)(2)(3). While non-small cell lung cancer (NSCLC) remains a major cause of death, many elective procedures and operations for the treatment of diseases have been delayed (4)(5)(6)(7)(8)(9). During the COVID-19 pandemic, some factors have led to changes in the management of patients with lung cancer.…”

Section: Introductionmentioning

confidence: 99%

Critical care for lung cancer patients: surgical treatment during COVID-19 pandemic

Gokce¹,

Hatipoglu²,

Akboga³

et al. 2022

BLL

View full text Add to dashboard Cite

BACKGROUND: During the COVID-19 pandemic, some factors have led to changes in the management of patients with lung cancer. In our study, we aimed to present our surgical treatment approach to patients with NSCLC during the COVID-19 pandemic. METHODS: Patients who underwent surgery for NSCLC in our thoracic surgery clinic between March 2020 and March 2021 were evaluated retrospectively. The patients operated on were retrospectively evaluated in terms of sex, age, tumor staging, lung resection type, histopathological type, COVID-19 status, length of stay, complications, and mortality. RESULTS: Thirty-fi ve patients, 27 men and 8 women, underwent surgery for lung cancer. The 2 most common types of surgery were lobectomy (in 32 patients) and pneumonectomy (in 3 patients). According to cancer staging based on 8th TNM, 14 patients were stage 2B, 12 patients were stage 2A, and 9 patients were stage 3A. The morbidity rate was 14 %. No postoperative mortality was observed. Nine patients had a history of COVID-19 before surgery. No signifi cant difference was found in terms of complications in patients with a preoperative history of COVID-19. In the postoperative period, COVID-19 was observed in no patient in our clinic. CONCLUSION: We think that surgical treatments should not be postponed for diseases such as lung cancer, where the mortality rate is high and early diagnosis and treatment are very important. There will be no delay or inadequacy in the treatment of patients if the rules determined during the COVID-19 pandemic and other types of pandemic possibly occurring in the future are followed (Tab. 1, Ref. 23).

show abstract

Section: Introductionmentioning

confidence: 99%

Critical care for lung cancer patients: surgical treatment during COVID-19 pandemic

Gokce¹,

Hatipoglu²,

Akboga³

et al. 2022

BLL

View full text Add to dashboard Cite

show abstract

“…All hospital strategies aimed at containing the infection by introducing isolation protocols (1)(2)(3). Many elective procedures and operations were postponed despite other diseases such as non-small cell lung cancer (NSCLC) continued to be an important cause of death (4)(5)(6)(7)(8)(9).…”

Section: Introductionmentioning

confidence: 99%

Perspective: Did Covid-19 Change Non-small Cell Lung Cancer Surgery Approach?

et al. 2021

View full text Add to dashboard Cite

The novel coronavirus (Covid-19), as of January 2021, infected more than 85 million people worldwide, causing the death of about 1,840 million. Italy had more than 2 million infected and about 75,000 deaths. Many hospitals reduced their ordinary activity by up to 80%, to leave healthcare staff, wards, and intensive care unit (ICU) beds available for the significant number of Covid-19 patients. All this resulted in a prolonged wait for hospitalization of all other patients, including those with non-small cell lung cancer (NSCLC) eligible for surgery. The majority of thoracic surgery departments changed the clinical-therapeutic path of patients, re-adapting procedures based on the needs dictated by the pandemic while not delaying the necessary treatment. The establishment of Covid-19-free hub centers allowed some elective surgery in NSCLC patients but most of the operations were delayed. The technology has partly facilitated patients' visits through telemedicine when security protocols have prevented face-to-face assessments. Multidisciplinary consultations had to deal also with the priority of the NSCLC cases discussed. Interpretation of radiologic exams had to take into account the differential diagnosis with Covid-19 infection. All the knowledge and experience of the past months reveal that the Covid-19 pandemic has not substantially changed the indications and type of surgical treatment in NSCLC. However, the diagnostic process has become more complex, requiring rigorous planning, thus changing the approach with the patients.

show abstract

Cancer du poumon à l’ère du COVID-19

Cited by 2 publications

References 26 publications

Critical care for lung cancer patients: surgical treatment during COVID-19 pandemic

Critical care for lung cancer patients: surgical treatment during COVID-19 pandemic

Perspective: Did Covid-19 Change Non-small Cell Lung Cancer Surgery Approach?

Contact Info

Product

Resources

About